Myomo, Inc. (MYO) stock
MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3030% below fair value
$0.88−0.04 (-4.23%)
Close on Nov 18, 2026Market cap $34.85MP/E –Yield –
Myomo cash
Cash and short-term investments held at the end of each period.
Myomo's cash was $13.45M at Jun 30, 2026. For fiscal 2025 it was $18.40M, down 26.1% from the year before. Over ten years it grew 33.3% a year on average. The highest annual figure on record is $24.90M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.40M | -26.1% |
| FY2024 | Dec 31, 2024 | $24.90M | +180.8% |
| FY2023 | Dec 31, 2023 | $8.87M | +65.8% |
| FY2022 | Dec 31, 2022 | $5.35M | -65.6% |
| FY2021 | Dec 31, 2021 | $15.52M | +26.8% |
| FY2020 | Dec 31, 2020 | $12.24M | +174.1% |
| FY2019 | Dec 31, 2019 | $4.47M | -31.7% |
| FY2018 | Dec 31, 2018 | $6.54M | -49.5% |
| FY2017 | Dec 31, 2017 | $12.96M | +1426.1% |
| FY2016 | Dec 31, 2016 | $849.17K | -18.6% |
| FY2015 | Dec 31, 2015 | $1.04M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $13.45M | -13.1% |
| Q1 FY2026 | Mar 31, 2026 | $15.70M | -34.9% |
| Q4 FY2025 | Dec 31, 2025 | $18.40M | -26.1% |
| Q3 FY2025 | Sep 30, 2025 | $12.55M | +89.6% |
| Q2 FY2025 | Jun 30, 2025 | $15.48M | +72.4% |
| Q1 FY2025 | Mar 31, 2025 | $24.09M | +119.9% |
| Q4 FY2024 | Dec 31, 2024 | $24.90M | +180.8% |
| Q3 FY2024 | Sep 30, 2024 | $6.62M | -40.4% |
| Q2 FY2024 | Jun 30, 2024 | $8.98M | +0.3% |
| Q1 FY2024 | Mar 31, 2024 | $10.96M | +18.3% |
| Q4 FY2023 | Dec 31, 2023 | $8.87M | +65.8% |
| Q3 FY2023 | Sep 30, 2023 | $11.12M | +49.9% |
| Q2 FY2023 | Jun 30, 2023 | $8.96M | -12.5% |
| Q1 FY2023 | Mar 31, 2023 | $9.26M | -28.4% |
| Q4 FY2022 | Dec 31, 2022 | $5.35M | -65.6% |
| Q3 FY2022 | Sep 30, 2022 | $7.42M | -41.1% |
| Q2 FY2022 | Jun 30, 2022 | $10.24M | -25.7% |
| Q1 FY2022 | Mar 31, 2022 | $12.94M | -25.5% |
| Q4 FY2021 | Dec 31, 2021 | $15.52M | +26.8% |
| Q3 FY2021 | Sep 30, 2021 | $12.61M | -5.3% |
| Q2 FY2021 | Jun 30, 2021 | $13.77M | +28.3% |
| Q1 FY2021 | Mar 31, 2021 | $17.37M | +26.6% |
| Q4 FY2020 | Dec 31, 2020 | $12.24M | +174.1% |
| Q3 FY2020 | Sep 30, 2020 | $13.32M | +207.7% |
| Q2 FY2020 | Jun 30, 2020 | $10.73M | +60.9% |
| Q1 FY2020 | Mar 31, 2020 | $13.73M | +48.7% |
| Q4 FY2019 | Dec 31, 2019 | $4.47M | -31.7% |
| Q3 FY2019 | Sep 30, 2019 | $4.33M | -52.4% |
| Q2 FY2019 | Jun 30, 2019 | $6.67M | -42.9% |
| Q1 FY2019 | Mar 31, 2019 | $9.23M | -34.6% |
| Q4 FY2018 | Dec 31, 2018 | $6.54M | -49.5% |
| Q3 FY2018 | Sep 30, 2018 | $9.09M | +83.4% |
| Q2 FY2018 | Jun 30, 2018 | $11.68M | +64.3% |
| Q1 FY2018 | Mar 31, 2018 | $14.12M | +869.6% |
| Q4 FY2017 | Dec 31, 2017 | $12.96M | +1426.1% |
| Q3 FY2017 | Sep 30, 2017 | $4.96M | +905.3% |
| Q2 FY2017 | Jun 30, 2017 | $7.11M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.46M | – |
| Q4 FY2016 | Dec 31, 2016 | $849.17K | – |
| Q3 FY2016 | Sep 30, 2016 | $493.21K | – |
See a number that looks wrong?